Showing results (781-790 of 2,811) with videos related to
Sort By:
Pageof 282
Expert Opinion on Drug Safety|May 17, 2021
Safety review of tenofovir disoproxil fumarate/emtricitabine pre-exposure prophylaxis for pregnant women at risk of HIV infectionRandy M Stalter, Jillian Pintye, Kenneth K MugwanyaExpert Opinion on Drug Safety|May 25, 2021
The long-term safety of chronic azithromycin use in adult patients with cystic fibrosis, evaluating biomarkers for renal function, hepatic function and electrical properties of the heartA M Akkerman-Nijland, J E Möhlmann, O W Akkerman, et al.Expert Opinion on Drug Safety|May 17, 2021
Newer formulations of intravenous iron: a review of their chemistry and key safety aspects - hypersensitivity, hypophosphatemia, and cardiovascular safetyIrina Blumenstein, Satish Shanbhag, Peter Langguth, et al.Expert Opinion on Drug Safety|May 21, 2021
Clinical profile of acute pancreatitis following treatment with protease inhibitors: a real-world analysis of post-marketing surveillance dataWangjun Qin, Bin Zhao, Yongguang Shang, et al.Expert Opinion on Drug Safety|February 3, 2023
Ubrogepant and rimegepant: systematic review, meta-analysis, and meta-regression of clinical studiesGuojun Dong, Naoko Adachi Kjærgaard, Saeed Shakibfar, et al.Expert Opinion on Drug Safety|February 3, 2023
Safety evaluation of axicabtagene ciloleucel for relapsed or refractory large B-cell lymphomaKarthik Nath, Kitsada Wudhikarn, Ana Alarcon Tomas, et al.Expert Opinion on Drug Safety|February 16, 2023
Sex differences in adverse drug reactions from Adalimumab and etanercept in patients with inflammatory rheumatic diseasesHelen R Gosselt, Jette A van Lint, Leanne J Kosse, et al.Expert Opinion on Drug Safety|February 16, 2023
Identification of adverse drug reactions that may be related to pharmacogenetics in a public hospital in the South of BrazilAmanda C Camargo, Ursula Matte, Mariana R BottonExpert Opinion on Drug Safety|March 8, 2023
Adverse effects of proton pump inhibitors (PPIs) on the renal system using data mining algorithms (DMAs)Devanshi Jain, Gazal Sharma, Anoop KumarExpert Opinion on Drug Safety|December 3, 2016
The safety of nivolumab for the treatment of advanced non-small cell lung cancerGiulio Metro, Biagio Ricciuti, Marta Brambilla, et al.Pageof 282